A groundbreaking alternative treatment for SARS-CoV-2 infections is being explored by researchers from the Council of Scientific and Industrial Research, National Laser Centre-South Africa, University of KwaZulu-Natal-South Africa, and University of Cape Town-South Africa. The study investigates the potential of Low-Level Laser Therapy (LLLT) in treating the virus, offering a new ray of hope in the battle against COVID-19.
SARS-CoV-2’s ability to undergo mutations poses a significant threat to public health, reducing vaccine effectiveness and increasing infectivity. To address this challenge, researchers are exploring the potential of Low-Level Laser Therapy (LLLT) as an alternative and effective method of controlling the virus.
In a pioneering study, researchers are investigating the impact of LLLT on SARS-CoV-2 infected cells, comparing the effects with uninfected cells. LLLT is a therapeutic approach that uses red and near-infrared light to promote healing, reduce pain, and restore function. This study aims to understand how LLLT can potentially combat the virus.
SARS-CoV-2, belonging to the coronavirus family, is a single-stranded RNA-enveloped virus that causes COVID-19. Unlike other human coronaviruses, SARS-CoV-2 has higher death rates, making it a formidable foe in the ongoing pandemic.
The SARS-CoV-2 genome is characterized by its 29,881 base pairs and 9860 amino acids. The virus’s surface is adorned with glycosylated S proteins, which are crucial for binding to host cells and facilitating viral entry.
LLLT works by exposing cells or tissues to low levels of red and near-infrared light, triggering cellular responses that promote healing and reduce inflammation. Initially described in 1967, LLLT has been successful in various applications, from treating sports injuries to managing chronic pain and even hair loss.
Although LLLT has found success in various biological applications, its use in treating viral infections has been limited. This study aims to bridge that gap by assessing the impact of LLLT on SARS-CoV-2-infected cells.
To address the challenges posed by SARS-CoV-2, the study proposes innovative treatment approaches, including laser waistcoats, hyperbaric oxygen chambers (HBOT), and nasal laser devices. These methods offer targeted treatment and could potentially reduce the severity of the infection.
The study’s findings suggest that LLLT can reduce SARS-CoV-2 infection in cells. While it is not a definitive cure, LLLT shows promise as a non-aggressive therapy in the fight against COVID-19.
Further investigations are needed to understand the mechanisms behind LLLT’s impact on SARS-CoV-2. The study also encourages additional research, including the use of transmission electron microscopy for a more comprehensive analysis.
The study acknowledges its limitations, including the use of pseudovirus samples instead of real samples. Future research plans involve more complex models to assess LLLT’s therapeutic potential against SARS-CoV-2.
The study’s findings have been published in the peer-reviewed Journal of Biophotonics, marking a promising stride toward innovative treatments for the ongoing pandemic.